BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3268061)

  • 1. A new surgical approach to vasodilating therapy in peripheral occlusive vascular disease.
    Horch R; Krönung G
    Nihon Geka Hokan; 1988 Nov; 57(6):487-92. PubMed ID: 3268061
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intra-arterial infusion therapy in thrombo-obliterating diseases of the lower limbs].
    Kurbangaleev SM; Savel'ev IuS
    Vestn Khir Im I I Grek; 1974 Oct; 113(10):68-71. PubMed ID: 4432347
    [No Abstract]   [Full Text] [Related]  

  • 3. [Complications of continuous intra-arterial infusion in patients with occlusive vascular diseases].
    Rudush VE
    Vestn Khir Im I I Grek; 1988 Mar; 140(3):93-4. PubMed ID: 3407092
    [No Abstract]   [Full Text] [Related]  

  • 4. [Intra-arterial vasodilatative infusion and normal blood supply in peripheral angiopathy].
    Bartusch M; Ridha G; Mörl H; Preuss EG
    Angiologica; 1973; 10(1):24-30. PubMed ID: 4710547
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intra-arterial drug therapy in arterial obstructions of the leg: value of high concentrations in the ischemic zones].
    Jorns G
    Phlebologie; 1979; 32(1):43-6. PubMed ID: 432288
    [No Abstract]   [Full Text] [Related]  

  • 6. [Duplex ultrasound measurement of morphologic parameters before and following repeated puncture of the femoral artery for intermittent infusion therapy].
    Ranke C; Creutzig A; Alexander K
    Vasa; 1990; 19(3):203-6. PubMed ID: 2238813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of the treatment of peripheral arterial diseases with PGE1].
    Borkowski M; Kruk M; Królicki L; Wojtal E; Malmurowicz L; Górewicz R; Laszuk D
    Pol Tyg Lek; 1990 Jun 18-25; 45(25-26):505-8. PubMed ID: 2287566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intravenous and intra-arterial prostaglandin E1 treatment in patients with stage IIb arterial occlusive disease].
    Rudofsky G
    Vasa Suppl; 1988; 23():121-5. PubMed ID: 3206330
    [No Abstract]   [Full Text] [Related]  

  • 9. Iontophoretic administration of prostaglandin E1 in peripheral arterial occlusive disease.
    Sakurai T; Yamamura K
    Ann Pharmacother; 2003 May; 37(5):747. PubMed ID: 12708957
    [No Abstract]   [Full Text] [Related]  

  • 10. Recanalization of chronic peripheral arterial occlusions by alternating intra-arterial rt-PA and PGE1.
    Kröger K; Hwang I; Rudofsky G
    Vasa; 1998 Feb; 27(1):20-3. PubMed ID: 9540428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-arterial and intravenous administration of prostaglandin E1 cause different changes to skin microcirculation in patients with peripheral arterial occlusive disease.
    Thum J; Caspary L; Creutzig A; Alexander K
    Vasa; 1998 May; 27(2):100-5. PubMed ID: 9612114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intra-arterial administration of penicillin and vasodilating agents in occlusive diseases of the peripheral arteries].
    Hubl S; Wesolowski J
    Pol Tyg Lek; 1973 Jul; 28(30):1150-1. PubMed ID: 4732712
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of intra-arterial and intravenous PGE1 infusions on transcutaneous oxygen pressure in patients with critical ischemia of the extremities].
    Weiss T; Griesshaber J; Rogatti W; Kistner O; Hsu E; Jansen T; Diehm C
    Vasa Suppl; 1991; 33():341-2. PubMed ID: 1788749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical trial of a new vasoactive drug F.I. 6714 administered intra-arterially in peripheral vascular diseases].
    Masini G
    Minerva Cardioangiol; 1975 Feb; 23(2):120-5. PubMed ID: 1095956
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mechanisms of action of prostaglandin E1 in therapy of peripheral arterial occlusive diseases].
    Weiss T
    Vasa; 2003 Nov; 32(4):187-92. PubMed ID: 14694766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Duplex ultrasound measurement of hemodynamic parameters at rest and following arterial stenosis: effect of intra-arterial infusion therapy with prostaglandin E1].
    Ranke C; Creutzig A; Alexander K
    Vasa Suppl; 1989; 27():353-5. PubMed ID: 2696104
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of infusion treatment once a day for 4 weeks with alprostadil-alpha-cyclodextrin on blood levels of endothelin-1 in patients with chronic obliterative arteriopathy of the legs at Leriche-Fontaine stage 2].
    Mangiafico RA; Malatino LS; Attinà T; Dell'Arte S; Messina R
    Minerva Cardioangiol; 1999 Dec; 47(12):652-3. PubMed ID: 10670246
    [No Abstract]   [Full Text] [Related]  

  • 18. [Indications for and effects of vasodilating agents, especially in cerebral and peripheral vascular sclerosis].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1981 Feb; 125(6):228-34. PubMed ID: 7207673
    [No Abstract]   [Full Text] [Related]  

  • 19. [Intra-arterial administration of prostaglandin E1 in occlusive arterial diseases].
    Davidović L; Vranes M; Cernak I; Kostić D; Lovrić A; Sagić D; Lotina S
    Srp Arh Celok Lek; 1992; 120(1-2):9-14. PubMed ID: 1641706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role and place of prolonged intra-arterial infusion in the treatment of obliterating arterial diseases of the lower extremities].
    Belichenko IA; Kungurtsev VV; Dibirov MD
    Khirurgiia (Mosk); 1980 Mar; (3):48-51. PubMed ID: 7366097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.